Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis

PURPOSE: This study evaluated the risk of medication-related osteonecrosis of the jaw (MRONJ) in patients with cancer who received denosumab or zoledronic acid (ZA) for treating bone metastasis. METHODS: The medical records of patients were retrospectively reviewed. Patients who did not undergo a de...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikesue, Hiroaki, Doi, Kohei, Morimoto, Mayu, Hirabatake, Masaki, Muroi, Nobuyuki, Yamamoto, Shinsuke, Takenobu, Toshihiko, Hashida, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794983/
https://www.ncbi.nlm.nih.gov/pubmed/34738163
http://dx.doi.org/10.1007/s00520-021-06634-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794983/
https://www.ncbi.nlm.nih.gov/pubmed/34738163
http://dx.doi.org/10.1007/s00520-021-06634-7

Ejemplares similares